,,ii  #aaith ,,congress  #b;d ,session  
,s4 #ceih  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,january #h    
7legislative day1 ,january #g71         
#bjbf,mrs4 ,shaheen 7for herself and    
,ms4 ,collins7 introduced the following 
bill2 which was read twice and referred 
to the ,committee on ,health1           
,education1 ,labor1 and ,pensions  ,a   
,,bill  ,to provide for the periodic    
issuance of up-to-date clinical guidance
 on addressing the health effects of    
per- and polyfluoroalkyl substances     
7,,pfas71 and for other purposes4  #a4  
,short title ,this ,act may be cited as 
the ,better ,care for ,,pfas ,patients  
,act of #bjbf4  #b4 ,,pfas health       
effects assessment1 recommendations1 and
 guidance  7a7 ,periodic assessment and 
recommendations  7#a7 ,agreement ,the   
,director of the ,agency for ,toxic     
,substances and ,disease ,registry 7in  
this section referred to as the         
,director7 shall enter into an agreement
 with the ,national ,academies of       

,sciences1 ,engineering1 and ,medicine  
7or another appropriate entity if the   
,national ,academies declines to enter  
into such agreement7 under which the    
,national ,academies or the other       
appropriate entity agrees-- 7,a7 to     
assess the health effects of per- and   
polyfluoroalkyl substances 7in this     
section referred to as ,,pfas7 that can 
be measured in human tissues2  7,b7 to  
formulate clinical recommendations on   
addressing such health effects2  7,c7   
not later than #b years after the date  
of entry into such agreement1 to        
complete the initial assessment under   
subparagraph 7,a7 and formulate the     
initial recommendations under           
subparagraph 7,b72 and  7,d7 to update  
the most recent assessment and          
recommendations under this paragraph--  
7i7 every #e years2 or  7ii7 more       
frequently as determined necessary by   
the ,director based on an assessment of 
the science4  7#b7 ,consultation ,in    
carrying out the assessments under      

paragraph 7#a71 the ,national ,academies
 of ,sciences1 ,engineering1 and        
,medicine or other appropriate entity   
shall engage with ,,pfas exposed        
communities and solicit input from      
members of such communities regarding   
their experiences with ,,pfas exposure1 
testing1 and clinical follow-up4  7#c7  
,timing of entry into agreement ,the    
,director shall enter into the agreement
 required by paragraph 7#a7 not later   
than #fj days after the date of         
enactment of this ,act4  7b7            
,up-to-,date guidance ,based on the     
results of the most recent assessment   
and recommendations under subsection    
7a71 the ,director1 in consultation with
 the entity with which the ,director    
enters into the agreement under         
subsection 7a71 shall-- 7#a7 not later  
than #e years after the date of entry   
into the agreement required by          
subsection 7a7-- 7,a7 issue up-to-date  
clinical guidance on addressing the     
health effects of ,,pfas2  7,b7 post    

such guidance on the public website of  
the ,agency for ,toxic ,substances and  
,disease ,registry2 and  7,c7           
disseminate such guidance to ,state and 
local public health authorities and     
appropriate health care professionals2  
and  7#b7 every #e years thereafter1 or 
more frequently as determined necessary 
by the ,director based on an assessment 
of the science1 issue1 post1 and        
disseminate up-to-date guidance as      
described in paragraph 7#a74